Abstract
The study assessed long-term safety and efficacy of intramyocardial injection of autologous bone-marrow derived mesenchymal stromal cells (BMMSCs) in patients with severe stable coronary artery disease (CAD) and refractory angina.
Original language | English |
---|---|
Journal | International Journal of Cardiology |
Volume | 170 |
Issue number | 2 |
Pages (from-to) | 246-51 |
Number of pages | 6 |
ISSN | 0167-5273 |
DOIs | |
Publication status | Published - 10 Dec 2013 |